Curculigoside
Curculigoside can prevent bone loss , improve osteogenesis and inhibit osteoclastogenesis of hAFSCs, suggesting its potential use to regulate hAFSC osteogenic differentiation for treating bone disorders.
Product Specifications
CAS Number
85643-19-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
466.43
Molecular Formula
C22H26O11
Notes
Research use only, not for human use.
Receptor
Antioxidant
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
APR08425G 0.1mg
Monoclonal MFN2 Antibody (monoclonal) (M03), Clone: 4H8
Sign In for Pricing
View Details 
MBS1479545-01 0.02 mg (E-Coli)
Recombinant Human Lipase member N (LIPN)
Sign In for Pricing
View Details 
MBS1479545-02 0.02 mg (Yeast)
Recombinant Human Lipase member N (LIPN)
Sign In for Pricing
View Details 
MBS1479545-03 0.1 mg (E-Coli)
Recombinant Human Lipase member N (LIPN)
Sign In for Pricing
View Details MBS1479545-04 0.1 mg (Yeast)
Recombinant Human Lipase member N (LIPN)
Sign In for Pricing
View Details MBS1479545-05 0.02 mg (Baculovirus)
Recombinant Human Lipase member N (LIPN)
Sign In for Pricing
View Details